Astellas, Amgen To Pay $125M To End Kickback Probe
By Aaron Leibowitz · April 25, 2019, 1:21 PM EDT
Astellas Pharma US Inc. and Amgen Inc. will pay a combined $125 million to settle allegations that they used charities to subsidize Medicare co-pays for their own drugs in what amounted...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login